This startup develops a cell precision control and diagnosis platform that automates massively parallel cellular processes within a single device. The platform enables rapid experimentation and data collection, providing researchers and healthcare providers with efficient workflows for scientific discovery.
Funding
$382.6K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for cell analysis often rely on bulk averaging, which obscures the unique characteristics of individual cells. Existing single-cell isolation techniques can be expensive, complex, and may not provide the required purity or throughput for certain applications, such as early cancer detection.
Solution
LMNTIC Biotech offers a cell precision control and diagnostics platform based on magnetic manipulation technology, enabling high-throughput, automated processing of cells at a single-cell resolution. The L:Cell™ Platform utilizes reusable microchips with precisely designed magnetic circuits to move and isolate individual cells with over 99.9% purity. This lab-on-a-chip system simplifies workflows, reduces hands-on time, and allows for flexible customization to meet specific research or diagnostic needs. The platform supports cell movement, separation, and isolation, allowing researchers to control various factors and observe cells at a single-cell level.
Target Audience
The primary target audience includes researchers in cell biology, in-vitro diagnostics, and drug discovery, as well as healthcare providers seeking advanced tools for cancer diagnosis and precision medicine.
Features
- Magnetic cell manipulation using low-cost, reusable cell circuits
- Precise control of cells based on size and surface markers
- Ability to sort cells into multiple populations with user-defined criteria
- Achieves >99.9% purity or capture rate during cell separation
- Isolates up to 100,000 cells into individual physical compartments
- Streamlined workflow combining 1st and 2nd enrichment steps into one process
- L:Biopsy application enables rapid and precise cancer diagnosis through high-purity CTC separation